Evaluation for new adjuvant therapy by transrectal ultrasound and its value in preoperative staging of rectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022298

Enrollment

Unknown

Registered

2019-04-03

Start date

2020-12-31

Completion date

Unknown

Last updated

2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Gold Standard:Clinical outcome

Index test:transrectal&#32

ultrasonography

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with rectal cancer and treated in our hospital

Exclusion criteria

Exclusion criteria: 1. Patients who can not match the position; 2. People with unstable health conditions have more serious cardiovascular, liver, and kidney diseases; with serious respiratory, endocrine, blood system diseases; 3. with serious infections; 4. Women during pregnancy; 5. According to the comprehensive opinion of the research team, those who do not meet the test plan; 6. participating in other clinical trial.

Design outcomes

Primary

Measure	Time frame
Two-dimensional ultrasonography;8/5000 Ultrasonic imaging;	—

Contacts

Public ContactYilin Yang

The Second Affiliated Hospital, Air Force Medical University

yangyl66@126.com+86 13892829252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026